Apyx shareholders approve 2026 Share Incentive Plan with 4M shares

Apyx Medical Corp

Stockholders approved 2026 Share Incentive Plan; 16,186,776 for, 2,755,882 against, 3,276,000 abstain, 7,677,267 broker non-votes.
Plan authorizes 4,000,000 shares for options and restricted stock to employees, directors, and consultants.
Five directors elected: Vizirgianakis, Goodwin, Waldman, Baylor-Henry, Levine; all received majority votes.
Say-on-pay advisory resolution approved: 21,458,554 for, 669,298 against, 90,806 abstain.
RSM US LLP ratified as independent auditor for FY2026: 29,814,618 for, 31,610 against, 49,697 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.